🔴 LIVE: The Secrets of ProPicks AI Success Revealed + November’s List FREEWatch Now

The morning catch up: ASX set to fall ahead of jobs data and China’s lack of fresh stimulus

Published 11/11/2024, 09:42 am
Updated 11/11/2024, 10:00 am
The morning catch up: ASX set to fall ahead of jobs data and China’s lack of fresh stimulus
UK100
-
US500
-
AXJO
-
DOW
-
GC
-
HG
-
LCO
-
CL
-
FTEU3
-

The ASX is set for a slow start to the week. ASX 200 futures are down 0.4% to 8,282 points despite Wall Street closing out its best week of the year on Friday. The index is set to fall on China's absence of fresh stimulus as Trump trade headwinds loom.

The ASX200 closed last week 176 points higher at 8,295, marking a 2.17% increase. The rally was driven by positive momentum from Wall Street in the wake of Donald Trump's re-election.

Sector performance was led by Information Technology, which surged 5.83%, followed by Industrials (+3.67%), Financials (+3.59%) and Consumer Discretionary (+2.90%).

In contrast, the Real Estate sector fell 1.54%, while Energy slipped 0.61%. Materials and Consumer Staples lagged, gaining just 0.47% and 0.73%, respectively.

Top-performing stocks included Sigma Pharma, which gained 29.59%, Appen (+27.08%), Articore (+15.38%) and Mayne Pharma (+15.12%).

The week’s biggest decliners were Domain, down 11.26%, DroneShield (-10.53%), Domino’s Pizza (-8.82%) and A2 Milk (-7.53%).

“The key event on the local data calendar this week is Thursday's labour force report for October,” notes IG Markets analyst Tony Sycamore. “Last month (September), the Australian economy added 64,100 jobs, significantly stronger than the 25,000 gain the market had expected. The unemployment rate stayed at 4.1% despite the participation rate increasing to a record high of 67.2%.

“This month, the preliminary expectation is that the Australian economy will create 20,000 jobs and that the unemployment rate to rise to 4.2%. The Australian interest rate market is pricing in 3bp of RBA rate cuts for December, with a first 25bp RBA rate cut not expected until May 2025.”

US stocks extend rally

US stocks extended their rally on Friday, reaching record highs amid optimism over Donald Trump's electoral victory and a subsequent interest rate cut by the Federal Reserve. For the week, the Nasdaq gained 5.41%, the S&P 500 rose 4.66% and the Dow Jones added 1,936 points, up 4.61%.

As final election results are still pending, the market awaits confirmation of a potential Republican 'Red Sweep', which could streamline the implementation of Trump's preferred trade and tax policies.

Looking ahead, market direction will hinge on whether Trump prioritises tax cuts or tariffs, each with markedly different impacts on equities. Notably, in 2016 Trump’s initial focus on tax cuts propelled markets higher, whereas later tariffs on China created stock market challenges through 2018 and 2019.

“Speaking of China, its NPC announcement on Friday fell short of market expectations,” notes Sycamore.

“The NPC approved a 5-year, Rmb10trn local government debt swap program with murky forward guidance hinting at only modest stimulus for housing and consumption.

"Nonetheless the measures announced provide additional confirmation that Beijing is recalibrating its economic strategy to tackle deflation and maintain stability. A move that has taken on additional importance following the release of soft Chinese inflation data over the weekend.

“Looking ahead the CPI report for October is the key US release this week. In September the annual rate of core inflation ticked up to 3.3% from a three-year low of 3.2%.

"The expectation for October is for the core rate to remain at 3.3% YoY. The rates market starts the week pricing in an 80% probability of another 25-basis point Fed cut at its meeting on December 18th.”

Declines in Europe

European share markets declined on Friday, with most sectors and major exchanges ending in negative territory. Mining stocks saw the steepest losses, dropping 3.9%, following China’s announcement of a 10 trillion yuan (US$1.4 trillion) debt package that fell short of investor expectations, leading to a retreat in metal prices.

  • The FTSEurofirst 300 index across the continent slipped 0.7%, marking its third consecutive week of declines, down 0.9% for the period.
  • In London, the UK FTSE 100 index shed 0.8% to reach a three-month low, recording a weekly loss of 1.3%.

Currencies and commodities

Currencies

Currencies were mixed against the US dollar in European and US trading.

  • The Euro declined from US$1.0796 to US$1.0688, stabilising near US$1.0720 at the US close.
  • The Australian dollar dipped from US66.56 cents to US65.58 cents, settling around US65.80 cents.
  • The Japanese yen strengthened from 152.94 to JPY152.17 per US dollar, closing near JPY152.65.

Commodities

Global oil prices dropped over 2% on Friday as concerns eased about long-term supply disruptions from a hurricane in the US Gulf of Mexico, while China’s economic stimulus measures underwhelmed traders.

  • Brent crude fell US$1.76, or 2.3%, to US$73.87 per barrel.
  • US Nymex crude lost US$1.98, or 2.7%, to US$70.38 per barrel.

Despite Friday's drop, oil prices were up over 1% for the week.

Base metals also retreated, with copper futures down 2.8% on investor disappointment with China’s limited fiscal stimulus, aimed at reviving its struggling economy. Aluminium futures dropped 3.5%.

For the week, copper fell 1.4% while aluminium posted a 0.6% gain.

Gold futures slipped US$11.00, or 0.4%, to US$2,694.80 per ounce on Friday, with spot gold trading near US$2,683. The precious metal declined 2.0% over the week, marking its largest weekly loss in over five months, driven by a stronger US dollar and investor recalibration of interest rate expectations following Donald Trump’s election win.

Iron ore futures declined US$1.40, or 1.3%, to US$103.82 per tonne as investors adopted caution amid weakening demand and in anticipation of China’s forthcoming fiscal stimulus announcement.

What about small caps?

The S&P/ASX Small Ordinaries finished Friday 1.21% higher to 3,169.60. It gained 1.05% for the week.

It is a steady start on the news front and you can read about the following and more throughout the day.

  • Imugene Ltd (ASX:IMU, OTC:IUGNF), a clinical-stage immuno-oncology company, has announced the dosing of the first patient in the intratumoural (IT) combination arm of its Phase 1 onCARlytics (CF33-CD19) clinical trial. This milestone, part of the OASIS trial, aims to evaluate the safety and efficacy of Imugene's CD19 oncolytic virotherapy in patients with advanced or metastatic solid tumours.
  • Orthocell Ltd (ASX:OCC, OTC:ORHHF), a regenerative medicine company, has appointed two key US-based executives to support the upcoming US market launch of its nerve repair product, Remplir™.
  • Nexus Minerals Ltd (ASX:NXM) has reported gold assay results from its recent regional aircore drilling program at the Wallbrook Gold Project in Western Australia’s north-eastern Goldfields region.
  • Strickland Metals Ltd (ASX:STK) has announced the discovery of a new zone of gold and base metal mineralisation through scout drilling at its Rogozna Gold and Base Metals Project in Serbia, which is fully owned and hosts an estimated 5.44 million ounces gold equivalent.
  • Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF), a developer of synthetic anti-infectives, has received Human Research Ethics Committee approval to initiate a Registrational Phase 3 clinical trial for RECCE® 327, a topical gel (R327G) for treating diabetic foot infections. This ethics approval allows Recce to proceed with the late-stage trial, following the completion of safety and efficacy testing requirements.
  • Read more on Proactive Investors AU

    Disclaimer

    Latest comments

    Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
    Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
    Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
    It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
    Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
    © 2007-2024 - Fusion Media Limited. All Rights Reserved.